Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data By: MarketWatch September 08, 2023 at 12:38 PM EDT Growing interest in AI-powered drug discovery draws some big investors–and regulatory questions Read More >> Related Stocks: NVIDIA Corp Recursion Pharmaceuticals, Inc. - Class A Common Stock Roche Holding AG Basel American Depositary Shares
